CT Select UK Equity Income Fund 4 IncRegister to Unlock Ratings |
Performance History | 31/08/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -11.4 | 13.1 | 1.7 | 10.7 | 13.2 | |
+/-Cat | 1.1 | -4.7 | 5.2 | 3.9 | 2.0 | |
+/-B’mrk | - | - | - | 3.0 | 1.7 | |
Category: UK Equity Income | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 27/09/2024 | GBX 119.00 | |
Day Change | 0.59% | |
Morningstar Category™ | UK Equity Income | |
IA (formerly IMA) Sector | UK Equity Income | |
ISIN | GB0033146340 | |
Fund Size (Mil) 27/09/2024 | GBP 53.10 | |
Share Class Size (Mil) 27/09/2024 | GBP 3.98 | |
Max Initial Charge | - | |
Ongoing Charge 12/04/2024 | 0.40% |
Investment Objective: CT Select UK Equity Income Fund 4 Inc |
The Fund aims to achieve an income yield which is higher than that of the FTSE All-Share Index, net of fees and in normal market conditions, with some long-term (over 5 years) capital growth. The Fund invests at least 80% in shares of UK companies. These are companies in any economic sector that may be listed, quoted or traded in the UK or elsewhere but which are incorporated, domiciled or conduct a significant portion of their business in the UK. Some companies may however have overseas earnings as part of their trading profits. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
David Moss 31/03/2017 | ||
Inception Date 10/10/2003 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for CT Select UK Equity Income Fund 4 Inc | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 9.08 |
Shell PLC | Energy | 5.96 |
Unilever PLC | Consumer Defensive | 5.53 |
Rio Tinto PLC Registered Shares | Basic Materials | 4.74 |
HSBC Holdings PLC | Financial Services | 4.30 |
Increase Decrease New since last portfolio | ||
CT Select UK Equity Income Fund 4 Inc |